Carpal Tunnel Syndrome Clinical Trial
Official title:
Assessment of the Effectiveness of Ultrasound-guided Acupuncture in the Management of Carpal Tunnel Syndrome
In clinical practice, carpal tunnel syndrome (CTS) is the common disease of peripheral
neuropathy and usually happened to female, mid-age population, overweight persons, and those
who overused their hands for work or production. Some research claimed this might be
correlated to anatomical characteristics such as the longer anteroposterior diameter or
smaller cross section area of the wrist. Preliminary symptoms often start with sensory
domain (pain, tingling, paresthesia and especially night awakening due to symptoms mentioned
above) and then progress to motor domain (thenar muscle atrophy and clumsiness) if left
untreated.
Depending on the severity, patient's willingness and convenience, there are many options for
CTS. For those whose symptoms are mild to moderate, conservative therapies are usually the
first choice, including physiotherapies, local injection and night splints. Local steroid is
proven to be effective to relieve the symptoms of CTS shortly up to 3 months. However, the
effects will decline gradually and repetitive injections is suggestive. The patients with
severe symptoms which comprise thenar muscle atrophy will be advised to receive
decompression surgery.the surgery can alleviate the illness with high success rate up to
70%. Unfortunately, there are still patients who will relapse or undergo side effects, for
example, finger weakness.
In recent years, acupuncture researches focused on CTS intervention have been outgrowing and
promising. Whereas, there are still lack of evidence which stands for the therapeutic
effects comparing with local steroid injection. This limits the built-up of suspect
mechanism of acupuncture intervention for CTS.
This is a preliminary, randomized and single-blinded study which started since 2016 and last
for a year. The investigators utilize ultrasound to guide the depth of needle penetration
which prevents unnecessarily tissues injury such as artery or dry needle injury. This
procedure also guarantees the needles lie directly on the upper surface of the median nerve.
One group will receive electrical stimulation and another won't. The investigators use
electromyography, cross-section area of median nerve, visual analog scale, Boston Carpal
Tunnel Syndrome Questionnaire, six-item scale, The disabilities of the arm, shoulder and
hand score and Jamar grip dynamometer as outcome measurements. The results gathered from two
experimental groups will be compared with the data from the control group whose participants
only receiving local steroid injection once in the first week. The participants are all
above 18 years old and complain of illness for a least 3 months without any surgery or local
injection for a least 1 year. The investigators set up strict exclusive criteria and sample
size estimation is 70.
Status | Not yet recruiting |
Enrollment | 72 |
Est. completion date | September 2017 |
Est. primary completion date | August 2017 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: 1. All participants are must above 20 years old, 2. All participants are willing to join and can be cooperated with all the interviews and examinations. 3. The symptoms are compatible with carpal tunnel syndrome, including numbness, pain, paresthesia, tingling, burning sensation over a least 2 fingers and hand motor limitation which are dominated by median nerve.These symptoms have to sustain for more than 3 months and be diagnosed by electromyography, physical examination and physicians. 4. Those who underwent local injection including glucose, steroid or anaphylaxis will be recruited if the treatments finished more than a year. Exclusion Criteria: 1. symptoms due to radiculopathy (When the patient also complains of symptoms radiating to the elbow or neck movement pain, the orthopedic doctor will make the definite diagnosis. ) 2. Those who underwent decompression surgery. 3. CTS due to traumatic injury (confirmed by image) 4. Those who underwent local injection within a year. 5. CTS due to rheumatoid arthritis 6. CTS due to cancer 7. CTS due to peripheral artery occlusive disease 8. Those who have past history of psychosis. 9. Pregnancy(every woman will be confirmed by urine pregnancy test) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Taipei Medical University Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | pain assessed on visual analog scale | 24 weeks | No | |
Primary | Boston Carpal Tunnel Syndrome Questionaire | 24 weeks | No | |
Primary | The 6-item CTS symptoms scale | 24 weeks | No | |
Primary | cross sectional area(CSA) of the median nerve | CSA of the median nerve below the distal wrist crease which is measured by the ultrasound(transverse view ) | 24 weeks | No |
Primary | hand grip power | Jamar Hand grip Dynamometer as the measuring tool | 24 weeks | No |
Primary | The Disabilities of the Arm, Shoulder and Hand (DASH) Score | 24 weeks | No | |
Primary | compound muscle action potential(CMAP) | The CMAP is a summated voltage response from the individual muscle fibre action potentials and measured in millivolts (mV). | 24 weeks | No |
Primary | Wrist-palm sensory nerve conduction velocity(Wrist-palm SNCV) | Wrist-palm SNCV (m/s) = distance between stimulation site 1 and site 2 (mm)/[latency wrist- latency palm(ms)]. | 24 weeks | No |
Primary | motor nerve conduction velocity(MNCV) | MNCV (m/s) = distance between stimulation site 1 and site 2 (mm)/[latency site 2 - latency site 1 (ms)]. | 24 weeks | No |
Primary | sensory nerve action potential(SNAP) | The sensory nerve action potential (SNAP) is obtained by electrically stimulating sensory fibres and recording the nerve action potential at a point further along that nerve. | 24 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05067205 -
Minimal Invasive Carpal Tunnel Release With the Novel Device
|
N/A | |
Completed |
NCT03184688 -
Platelet Rich Plasma for Carpal Tunnel Syndrome
|
N/A | |
Completed |
NCT03582735 -
Preoperative Neuromobilization Exercises for Individuals With Carpal Tunnel Syndrome
|
N/A | |
Completed |
NCT05490420 -
Effects of Upper Extremity Manual Lymphatic Drainage on Symptom Severity, Hand Functions, Electrophysiological and Ultrasonographic Measurements in Carpal Tunnel Syndrome
|
N/A | |
Recruiting |
NCT05970692 -
Cross-Cultural Adaptation and Psychometric Validation of the Turkish Version of Atroshi-Lyrén 6-item Symptoms Scale
|
||
Completed |
NCT04043780 -
Clinical Validation of a Decompression Prototype Splint for Patients With Carpal Tunel Syndrome
|
N/A | |
Completed |
NCT03880812 -
Cost Information on Carpal Tunnel Syndrome Treatment Decisions
|
N/A | |
Completed |
NCT06464809 -
Treatment Intervention of Patients With Carpal Tunnel Syndrome (CTS)
|
N/A | |
Recruiting |
NCT05372393 -
Carpal Tunnel Release Under Local Anaesthesia With or Without Distal Median Nerve Block
|
N/A | |
Recruiting |
NCT05328180 -
aDjunct bicarbonatE in Local anaesthesIa for CarpAl Tunnel rElease (DELICATE)
|
N/A | |
Recruiting |
NCT05503719 -
An Absorbable Suture Versus a Non-absorbable Suture in Carpal Tunnel Release, a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT05466162 -
Soft Tissue Massage Along With Mobilization Technique on Symptoms and Functional Status of Carpal Tunnel Syndrome
|
N/A | |
Completed |
NCT04060875 -
Research Protocol for Karuna Labs Inc.: Safety and Efficacy of Virtual Reality Graded Motor Imagery for Chronic Pain
|
||
Not yet recruiting |
NCT06294821 -
4AP to Delay Carpal Tunnel Release (CTR)
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04328805 -
Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome.
|
Phase 4 | |
Terminated |
NCT02791529 -
Scalpel Versus Electrocautery for Surgical Skin Incision in Open Carpal Tunnel Release
|
Phase 1 | |
Completed |
NCT02141035 -
Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT01887145 -
Comparison of Long-term Outcomes Following Endoscopic or Open Surgery for Carpal Tunnel Syndrome
|
N/A | |
Recruiting |
NCT01897272 -
Post-Operative Splinting After Short-Incision Carpal Tunnel Release: a Prospective Study
|
N/A | |
Completed |
NCT01394822 -
Neuromuscular Ultrasound for Focal Neuropathies
|
N/A |